These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980 [TBL] [Abstract][Full Text] [Related]
44. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia. Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407 [TBL] [Abstract][Full Text] [Related]
45. What is the optimal induction strategy for older patients? Estey E Best Pract Res Clin Haematol; 2011 Dec; 24(4):515-22. PubMed ID: 22127314 [TBL] [Abstract][Full Text] [Related]
46. Has there been progress in the treatment of older patients with acute myeloid leukemia? Erba HP Best Pract Res Clin Haematol; 2010 Dec; 23(4):495-501. PubMed ID: 21130413 [TBL] [Abstract][Full Text] [Related]
47. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia. Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545 [TBL] [Abstract][Full Text] [Related]
48. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M; Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922 [TBL] [Abstract][Full Text] [Related]
50. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Lekakis L; de Lima M Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050 [TBL] [Abstract][Full Text] [Related]
51. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087 [TBL] [Abstract][Full Text] [Related]
53. Advances in the management of acute myeloid leukemia in older adult patients. Rogers BB Oncol Nurs Forum; 2010 May; 37(3):E168-79. PubMed ID: 20439202 [TBL] [Abstract][Full Text] [Related]
54. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
55. Acute myeloid leukemia. Stone RM; O'Donnell MR; Sekeres MA Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679 [TBL] [Abstract][Full Text] [Related]
56. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Petersdorf SH; Rankin C; Head DR; Terebelo HR; Willman CL; Balcerzak SP; Karnad AB; Dakhil SR; Appelbaum FR Am J Hematol; 2007 Dec; 82(12):1056-62. PubMed ID: 17696203 [TBL] [Abstract][Full Text] [Related]
57. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia. Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639 [TBL] [Abstract][Full Text] [Related]
58. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience. Yavuz S; Paydas S; Disel U; Sahin B Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532 [TBL] [Abstract][Full Text] [Related]
59. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia. Hamadani M; Awan FT Hematol Oncol; 2010 Mar; 28(1):3-12. PubMed ID: 19645073 [TBL] [Abstract][Full Text] [Related]
60. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Willemze R; Labar B Semin Hematol; 2007 Oct; 44(4):267-73. PubMed ID: 17961726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]